Newcourt Acquisition Corp
IPO Proceeds, $M | $250.00M |
---|---|
IPO Date | Oct 20, 2021 |
CEO | Marc Balkin |
Left Lead | Cantor Fitzgerald |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 15 + 6 + 6 + 1 |
IPO Sector | Financial â–¶ |
IPO Geography | EEMEA |
Target Company | Psyence Biomed Corp |
Deal Announced | Jan 9, 2023 |
Deal Size, $M | $111.00M |
Deal Sector | Healthcare |
Deal Geography | Global |
SEC Filings |
www.sec.gov |
Approval Vote | Jan 18, 2024 |
Amendment Vote | Jan 22, 2024 |
Closing Date | Jan 25, 2024 |
Price | $1.24 |
---|---|
Last closing price | $1.26 |
H/L, today | $1.23 / $1.25 |
Volume, today | 47,223 |
Volume, 3-month avg. | N/A |
No credit card required
Sign in for more on Newcourt Acquisition Corp:
- Structure and cap table
- 6 directors & officers
- 49 filings and events
- 1 underwriters
- 2 deal advisors
- 3 legal advisors